देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
AZELASTINE HYDROCHLORIDE (UNII: 0L591QR10I) (AZELASTINE - UNII:ZQI909440X)
Amneal Pharmaceuticals LLC
NASAL
PRESCRIPTION DRUG
Azelastine HCl nasal spray, 0.15% is indicated for the relief of the symptoms of seasonal allergic rhinitis in patients 6 years of age and older and perennial allergic rhinitis in patients 6 years of age and older. None. Risk Summary Limited data from post-marketing experience over decades of use with azelastine HCl in pregnant women have not identified any drug associated risks of miscarriage, birth defects, or other adverse maternal or fetal outcomes. In animal reproduction studies, there was no evidence of fetal harm at oral doses approximately 4 times the clinical daily dose. Oral administration of azelastine HCl to pregnant mice, rats, and rabbits, during the period of organogenesis, produced developmental toxicity that included structural abnormalities, decreased embryo-fetal survival, and decreased fetal body weights at doses 180 times and higher than the maximum recommended human daily intranasal dose (MRHDID) of 1.644 mg. However, the relevance of these findings in animals to pregnant women was consi
Azelastine HCl nasal spray, 0.15% is supplied as a 30 mL package (NDC 65162-706-84) delivering 200 metered sprays in a high-density polyethylene (HDPE) bottle fitted with a metered-dose spray pump unit. The spray pump unit consists of a nasal spray pump fitted with a white safety clip and a white or clear plastic dust cover. The net content of the bottle is 30 mL (net weight 30 gm of solution). The 30 mL bottle contains 45 mg (1.5 mg/mL) of azelastine HCl, USP. After priming [see Dosage and Administration (2.3)] , each spray delivers a fine mist containing a mean volume of 0.137 mL solution containing 205.5 mcg of azelastine HCl, USP. The correct amount of medication in each spray cannot be assured before the initial priming and after 200 sprays for the 30 mL bottle have been used, even though the bottle is not completely empty. The bottle should be discarded after 200 sprays have been used. Azelastine HCl nasal spray, 0.15% should not be used after the expiration date “EXP” printed on the medicine label and carton. Storage Store upright at controlled room temperature 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing.
Abbreviated New Drug Application
AZELASTINE HYDROCHLORIDE- AZELASTINE HYDROCHLORIDE SPRAY, METERED AMNEAL PHARMACEUTICALS LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE AZELASTINE HYDROCHLORIDE NASAL SPRAY SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR AZELASTINE HYDROCHLORIDE NASAL SPRAY. AZELASTINE HYDROCHLORIDE NASAL SPRAY, FOR INTRANASAL USE INITIAL U.S. APPROVAL: 1996 RECENT MAJOR CHANGES Indications and Usage (1) 06/2021 Dosage and Administration, Recommended Dosage for Seasonal Allergic Rhinitis (2.1) 06/2021 Dosage and Administration, Recommended Dosage for Perennial Allergic Rhinitis (2.2) 06/2021 INDICATIONS AND USAGE Azelastine hydrochloride (HCl) nasal spray, 0.15% is an H -receptor antagonist indicated for the relief of the symptoms of: Seasonal allergic rhinitis in patients 6 years of age and older. (1.1) Perennial allergic rhinitis in patients 6 years of age and older. (1.1) DOSAGE AND ADMINISTRATION For intranasal use only (2.3). Seasonal allergic rhinitis: _6 to 11 years: _Azelastine HCl nasal spray, 0.15%: 1 spray per nostril twice daily (2.1) _Adults and adolescents 12 years of age and older:_ Azelastine HCl nasal spray, 0.15%: 1 or 2 sprays per nostril twice daily (2.1), or Azelastine HCl nasal spray, 0.15%: 2 sprays per nostril once daily (2.1) Perennial allergic rhinitis: _6 to 11 years: _Azelastine HCl nasal spray, 0.15%: 1 spray per nostril twice daily (2.2) _ _ _Adults and adolescents 12 years of age and older:_ Azelastine HCl nasal spray, 0.15%: 2 sprays per nostril twice daily (2.2) Prime azelastine HCl nasal spray, 0.15% before initial use and when it has not been used for 3 or more days. (2.3) DOSAGE FORMS AND STRENGTHS Nasal spray solution available in one dosage strength: Azelastine HCl nasal spray 0.15%: 205.5 mcg of azelastine HCl, USP in each 0.137 mL spray (3). CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS Somnolence: Avoid engaging in hazardous occupations requiring complete mental alertness such as driving or operatin पूरा दस्तावेज़ पढ़ें